Company News
Dr. Reddy's Receives Brazil Semaglutide Generic Approval
Dr. Reddy's Laboratories received ANVISA marketing authorization for its generic semaglutide injection in Brazil for type 2 diabetes treatment.
The approved product is a once-weekly injectable pen ava
